Details of the Drug
General Information of Drug (ID: DMWDYLR)
Drug Name |
4,6-dinitrobenzo[c][1,2,5]thiadiazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4,6-Dinitro-2,1,3-benzothiadiazole; 4,6-dinitrobenzo[c][1,2,5]thiadiazole; CHEMBL206140; 16408-06-3; NSC202427; AC1L76UW; AC1Q1Y7D; C6H2N4O4S; DTXSID90308123; MolPort-000-820-133; BYLOIWCTRDPRTP-UHFFFAOYSA-N; ZINC1736331; STK744333; BDBM50182130; 5,7-dinitro-2,1,3-benzothiadiazole; AKOS000544790; NSC-202427; MCULE-2301273439; 4,6-dinitrobenzo[c]1,2,5-thiadiazole; 4,6-Dinitro-benzo[1,2,5]thiadiazole; 2,1,3-Benzothiadiazole, 4,6-dinitro-; 4,6-Dinitro-2,1,3-benzothiadiazole #; NCI60_001699; ST032375; BAS 00731156
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 226.17 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||